Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 138 for:    NY-ESO-1

A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma (NY-ESO-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01343043
Recruitment Status : Active, not recruiting
First Posted : April 27, 2011
Last Update Posted : June 14, 2019
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline